semaglutide mental health side effects and Anxiety: What You Need to Know semaglutide depression side effects Psychiatric

Patients who might be considered for GLP-1 therapy (within licensed indications) and who may experience secondary benefits for binge eating behaviours include: Individuals with binge eating disorder and type 2 diabetes , where GLP-1 agonists address the primary diabetes indication whilst potentially helping with eating patterns Those with BED and obesity who meet NHS eligibility criteria for weight management medications (as defined by NICE TA875 for semaglutide or TA664 for liraglutide, which are narrower than the marketing authorisation) Patients who have not responded adequately to psychological interventions such as cognitive behavioural therapy (CBT) and who have concurrent metabolic conditions Those experiencing significant food cravings and loss-of-control eating as part of their weight management challenges However, important cautions and considerations apply

Incretin hormones, along with the chemically similar GLP-1 receptor agonists, slow gut motility and, therefore, slow the emptying of the gastrointestinal tract

Low blood sugar can occur, especially if Ozempic is combined with insulin or certain diabetes medications

How long does it take for GHRP-6 to kick in

Your PlexusDx provider screens for these conditions and advises whether treatment is appropriate for your health status